The Role of Aromatase Inhibitors in the Treatment of Infertility in Obese Male.

Trial Profile

The Role of Aromatase Inhibitors in the Treatment of Infertility in Obese Male.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 12 Apr 2016

At a glance

  • Drugs Anastrozole (Primary)
  • Indications Male infertility
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 May 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 15 Jun 2012 Planned End Date changed from 1 Jun 2012 to 1 Jun 2014 as reported by ClinicalTrials.gov record.
    • 21 Jul 2010 Planned end date changed from 1 Jun 2010 to 1 Jun 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top